Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q37829240
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010711.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q37829240
|
024
|
|
|
‡a
0000-0003-4741-8415
‡2
orcid
|
024
|
|
|
‡a
7102792651
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q37829240
|
100
|
0 |
|
‡a
José C. Machado
‡c
researcher
‡9
en
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
José C. Machado
‡c
investigador
‡9
es
|
400
|
0 |
|
‡a
José C. Machado
‡c
ricercatore
‡9
it
|
400
|
0 |
|
‡a
José C Machado
‡c
onderzoeker
‡9
nl
|
670
|
|
|
‡a
Author's A novel 25 bp tandem repeat within the human trefoil peptide gene TFF2 in 21q22.3: polymorphism and mammalian evolution
|
670
|
|
|
‡a
Author's A novel method for genotyping the Helicobacter pylori vacA intermediate region directly in gastric biopsy specimens
|
670
|
|
|
‡a
Author's A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma
|
670
|
|
|
‡a
Author's Ancillary Studies, Including Immunohistochemistry and Molecular Studies, in Lung Cytology.
|
670
|
|
|
‡a
Author's Apolipoprotein E e4 allele does not increase the risk of early postoperative delirium after major surgery
|
670
|
|
|
‡a
Author's Association between cytokine gene polymorphisms and gastric precancerous lesions: systematic review and meta-analysis
|
670
|
|
|
‡a
Author's Association between functional EGF+61 polymorphism and glioma risk.
|
670
|
|
|
‡a
Author's beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer.
|
670
|
|
|
‡a
Author's Bone mass of female dance students prior to professional dance training: A cross-sectional study
|
670
|
|
|
‡a
Author's Bone mineral density in vocational and professional ballet dancers
|
670
|
|
|
‡a
Author's C/EBPbeta is over-expressed in gastric carcinogenesis and is associated with COX-2 expression
|
670
|
|
|
‡a
Author's C/EBPα expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis
|
670
|
|
|
‡a
Author's C/EBPβ regulates homeostatic and oncogenic gastric cell proliferation
|
670
|
|
|
‡a
Author's CagA associates with c-Met, E-cadherin, and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype
|
670
|
|
|
‡a
Author's CCAAT/enhancer binding protein β
|
670
|
|
|
‡a
Author's CCAAT/enhancer binding protein β (C/EBPβ) isoforms as transcriptional regulators of the pro-invasive CDH3/P-cadherin gene in human breast cancer cells
|
670
|
|
|
‡a
Author's Circulating Tumor DNA: A Step into the Future of Cancer Management
|
670
|
|
|
‡a
Author's Clinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma
|
670
|
|
|
‡a
Author's Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression
|
670
|
|
|
‡a
Author's Common Vascular Endothelial Growth Factor Variants and Risk for Posttransplant Kaposi Sarcoma
|
670
|
|
|
‡a
Author's Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas.
|
670
|
|
|
‡a
Author's Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid
|
670
|
|
|
‡a
Author's Correction for Ferreira et al., A Novel Method for Genotyping the Helicobacter pylori vacA Intermediate Region Directly in Gastric Biopsy Specimens
|
670
|
|
|
‡a
Author's Cribriform-Morular Variant of Papillary Thyroid Carcinoma Displaying Poorly Differentiated Features
|
670
|
|
|
‡a
Author's Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome
|
670
|
|
|
‡a
Author's Critérios de diagnóstico da Síndrome de Brugada. Podemos melhorar?
|
670
|
|
|
‡a
Author's Crosstalk between Helicobacter pylori and gastric epithelial cells is impaired by docosahexaenoic acid
|
670
|
|
|
‡a
Author's Current thoughts on the histopathogenesis of gastric cancer.
|
670
|
|
|
‡a
Author's Detection of Common and Less FrequentEGFRMutations in Cytological Samples of Lung Cancer
|
670
|
|
|
‡a
Author's Diagnostic challenges of Marfan syndrome in an XYY young man
|
670
|
|
|
‡a
Author's Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome
|
670
|
|
|
‡a
Author's Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus
|
670
|
|
|
‡a
Author's Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization
|
670
|
|
|
‡a
Author's Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori.
|
670
|
|
|
‡a
Author's E-Cadherin
|
670
|
|
|
‡a
Author's E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
|
670
|
|
|
‡a
Author's E-cadherin changes in gastric carcimona
|
670
|
|
|
‡a
Author's E-cadherin gene
|
670
|
|
|
‡a
Author's E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma
|
670
|
|
|
‡a
Author's E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas
|
670
|
|
|
‡a
Author's E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells
|
670
|
|
|
‡a
Author's E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2
|
670
|
|
|
‡a
Author's E-cadherin mutations in gastric carcinoma
|
670
|
|
|
‡a
Author's EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells.
|
670
|
|
|
‡a
Author's Epidermal growth factor receptor mutation study for 5 years, in a population of patients with non-small cell lung cancer
|
670
|
|
|
‡a
Author's Erratum to: Pathogenesis of Gastric Cancer: Genetics and Molecular Classification
|
670
|
|
|
‡a
Author's Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice.
|
670
|
|
|
‡a
Author's European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients
|
670
|
|
|
‡a
Author's Exosomes and Immune Response in Cancer: Friends or Foes?
|
670
|
|
|
‡a
Author's Expression pattern of gastrointestinal markers in native colorectal epithelium, lesions, and carcinomas
|
670
|
|
|
‡a
Author's Extensive genetic polymorphism of peptidases A, B, C, and D, in wild rabbit (Oryctolagus cuniculus) populations from the Iberian Peninsula
|
670
|
|
|
‡a
Author's Female sex hormone receptors are not involved in gastric carcinogenesis. A biochemical and immunohistochemical study.
|
670
|
|
|
‡a
Author's First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies?
|
670
|
|
|
‡a
Author's First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile
|
670
|
|
|
‡a
Author's First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia
|
670
|
|
|
‡a
Author's G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer
|
670
|
|
|
‡a
Author's Gastric cancer: Basic aspects
|
670
|
|
|
‡a
Author's Gastric cancer pathogenesis
|
670
|
|
|
‡a
Author's Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6)
|
670
|
|
|
‡a
Author's Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-ray cross-complementing group 1
|
670
|
|
|
‡a
Author's Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-ray cross-complementing group 1 (XRCC1).
|
670
|
|
|
‡a
Author's Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota
|
670
|
|
|
‡a
Author's Genetic and epigenetic alteration in gastric carcinogenesis
|
670
|
|
|
‡a
Author's Genetic Changes of CEBPA in Cancer: Mutations or Polymorphisms?
|
670
|
|
|
‡a
Author's Genetic screening for familial gastric cancer
|
670
|
|
|
‡a
Author's Genetic Variants Are Not Rare in ICD Candidates with Dilated Cardiomyopathy: Time for Next-Generation Sequencing?
|
670
|
|
|
‡a
Author's Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
|
670
|
|
|
‡a
Author's Genetic variants in the IL1A gene region contribute to intestinal-type gastric carcinoma susceptibility in European populations
|
670
|
|
|
‡a
Author's Genetic variation in Wnt/β-catenin and ER signalling pathways in female and male elite dancers and its associations with low bone mineral density: a cross-section and longitudinal study
|
670
|
|
|
‡a
Author's Genetics of glucocorticoid regulation and posttraumatic stress disorder--What do we know?
|
670
|
|
|
‡a
Author's Glycans as immune checkpoints: removal of branched N-glycans enhances immune recognition preventing cancer progression
|
670
|
|
|
‡a
Author's Granulomatous-like immune reaction and hepatic fibrosis induced by Schistosoma haematobium immature worms
|
670
|
|
|
‡a
Author's GRIM-19 mutations are not associated with Crohn's disease.
|
670
|
|
|
‡a
Author's Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma
|
670
|
|
|
‡a
Author's Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner
|
670
|
|
|
‡a
Author's Helicobacter pylori's cholesterol uptake impacts resistance to docosahexaenoic acid.
|
670
|
|
|
‡a
Author's Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome.
|
670
|
|
|
‡a
Author's ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation
|
670
|
|
|
‡a
Author's Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands
|
670
|
|
|
‡a
Author's Identification of germ-line E-cadherin mutations in gastric cancer families of European origin
|
670
|
|
|
‡a
Author's IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal.
|
670
|
|
|
‡a
Author's IL-1RN VNTR polymorphism as a susceptibility marker for nasopharyngeal carcinoma in Portugal.
|
670
|
|
|
‡a
Author's Inactivation of estrogen receptor by Schistosoma haematobium total antigen in bladder urothelial cells
|
670
|
|
|
‡a
Author's Induction of apoptosis increases sensitivity to detect cancer mutations in plasma
|
670
|
|
|
‡a
Author's Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL.
|
670
|
|
|
‡a
Author's Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma
|
670
|
|
|
‡a
Author's Interleukin-1B signalling leads to increased survival of gastric carcinoma cells through a CREB-C/EBPβ-associated mechanism
|
670
|
|
|
‡a
Author's KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression
|
670
|
|
|
‡a
Author's Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma.
|
670
|
|
|
‡a
Author's LRP5 gene polymorphisms and radiographic joint damage in rheumatoid arthritis patients
|
670
|
|
|
‡a
Author's Microsatellite instability in hyperplastic and adenomatous polyps of the stomach
|
670
|
|
|
‡a
Author's Mitochondrial DNA alteration in gastric cancer
|
670
|
|
|
‡a
Author's Mixed carcinoma of the stomach: a clinicopathological entity
|
670
|
|
|
‡a
Author's Molecular characterization of Portuguese patients with dilated cardiomyopathy
|
670
|
|
|
‡a
Author's Molecular pathogenesis of gastric cancer.
|
670
|
|
|
‡a
Author's MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile
|
670
|
|
|
‡a
Author's Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex.
|
670
|
|
|
‡a
Author's Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer
|
670
|
|
|
‡a
Author's New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression
|
670
|
|
|
‡a
Author's New massive parallel sequencing approach improves the genetic characterization of congenital myopathies
|
670
|
|
|
‡a
Author's NOD2/CARD15 and TNFA, But Not ILLB and ILLRN, are Associated With Crohnʼs Disease
|
670
|
|
|
‡a
Author's Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting.
|
670
|
|
|
‡a
Author's Oral and gastric Helicobacter pylori: effects and associations
|
670
|
|
|
‡a
Author's Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer
|
670
|
|
|
‡a
Author's Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population
|
670
|
|
|
‡a
Author's Pathogenesis of Gastric Cancer.
|
670
|
|
|
‡a
Author's Pathogenesis of Gastric Cancer: Genetics and Molecular Classification.
|
670
|
|
|
‡a
Author's Pathogenesis of Helicobacter pylori Infection
|
670
|
|
|
‡a
Author's Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa.
|
670
|
|
|
‡a
Author's Patterns of beta-catenin expression in gastric carcinoma: clinicopathological relevance and mutation analysis.
|
670
|
|
|
‡a
Author's Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes
|
670
|
|
|
‡a
Author's Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II).
|
670
|
|
|
‡a
Author's Polymorphisms in Inflammatory Response Genes and Their Association With Gastric Cancer: A HuGE Systematic Review and Meta-Analyses
|
670
|
|
|
‡a
Author's Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease
|
670
|
|
|
‡a
Author's Prevalence of low bone mineral density in female dancers
|
670
|
|
|
‡a
Author's Primary signet-ring cell carcinomas of the lung
|
670
|
|
|
‡a
Author's Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas
|
670
|
|
|
‡a
Author's pS2 protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric study
|
670
|
|
|
‡a
Author's Re. ‘Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways’
|
670
|
|
|
‡a
Author's Review: Gastric malignancies: Basic aspects
|
670
|
|
|
‡a
Author's Role of epidermal growth factor mutational status for distinction between recurrent lung cancer and second primary lung cancer: case report
|
670
|
|
|
‡a
Author's Routine characterization of biomarkers in non-small cell lung carcinoma: how much is enough?
|
670
|
|
|
‡a
Author's Schistosoma haematobium and bladder cancer: what lies beneath?
|
670
|
|
|
‡a
Author's Schistosoma haematobium and Schistosomiasis mansoni: production of an estradiol-related compound detected by ELISA.
|
670
|
|
|
‡a
Author's Schistosoma haematobium: identification of new estrogenic molecules with estradiol antagonistic activity and ability to inactivate estrogen receptor in mammalian cells
|
670
|
|
|
‡a
Author's Schistosoma haematobium total antigen induces increased proliferation, migration and invasion, and decreases apoptosis of normal epithelial cells
|
670
|
|
|
‡a
Author's Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study
|
670
|
|
|
‡a
Author's Systematic review: gastric microbiota in health and disease
|
670
|
|
|
‡a
Author's Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation
|
670
|
|
|
‡a
Author's Targeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer
|
670
|
|
|
‡a
Author's The interferon gamma receptor 1
|
670
|
|
|
‡a
Author's The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma
|
670
|
|
|
‡a
Author's The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population
|
670
|
|
|
‡a
Author's The number of Helicobacter pylori CagA EPIYA C tyrosine phosphorylation motifs influences the pattern of gastritis and the development of gastric carcinoma.
|
670
|
|
|
‡a
Author's The prevalence of PIK3CA mutations in gastric and colon cancer.
|
670
|
|
|
‡a
Author's The Two Faces of Tumor-Associated Macrophages and Their Clinical Significance in Colorectal Cancer
|
670
|
|
|
‡a
Author's Trefoil factors: from ulceration to neoplasia.
|
670
|
|
|
‡a
Author's Tumor Necrosis Factor Alpha Extended Haplotypes and Risk of Gastric Carcinoma
|
670
|
|
|
‡a
Author's Tumourigenic effect of Schistosoma haematobium total antigen in mammalian cells.
|
670
|
|
|
‡a
Author's Urothelial dysplasia and inflammation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium
|
670
|
|
|
‡a
Author's Value of molecular diagnosis in a family with Marfan syndrome and an atypical vascular phenotype
|
670
|
|
|
‡a
Author's Variable distribution of TFF2
|
670
|
|
|
‡a
Author's Variable distribution of TFF2 (Spasmolysin) alleles in Europeans does not indicate predisposition to gastric cancer
|
670
|
|
|
‡a
Author's Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000068787824
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/98905645
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/SUDOC|164701680
|
909
|
|
|
‡a
(orcid) 0000000347418415
‡9
1
|
909
|
|
|
‡a
(scopus) 7102792651
‡9
1
|
919
|
|
|
‡a
cribriformmorularvariantofpapillarythyroidcarcinomadisplayingpoorlydifferentiatedfeatures
‡A
Cribriform-Morular Variant of Papillary Thyroid Carcinoma Displaying Poorly Differentiated Features
‡9
1
|
919
|
|
|
‡a
ecadheringenemutationsprovideageneticbasisforthephenotypicdivergenceofmixedgastriccarcinomas
‡A
E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas
‡9
1
|
919
|
|
|
‡a
ecadheringermlinemissensemutationsandcellphenotypeevidencefortheindependenceofcellinvasiononthemotilecapabilitiesofthecells
‡A
E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells
‡9
1
|
919
|
|
|
‡a
ecadheringenecdh1promotermethylationasthe2hitinsporadicdiffusegastriccarcinoma
‡A
E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma
‡9
1
|
919
|
|
|
‡a
welldifferentiatedpapillarymesotheliomaclusteringinaportuguesefamilywithagermlinebap1mutation
‡A
Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.
‡9
1
|
919
|
|
|
‡a
gastriccarcinomaexhibitsdistincttypesofcelldifferentiationanimmunohistochemicalstudyoftrefoilpeptidestff1andtff2andmucinsmuc1muc2muc5acandmuc6
‡A
Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6)
‡9
1
|
919
|
|
|
‡a
gastriccancerpathogenesis
‡A
Gastric cancer pathogenesis
‡9
1
|
919
|
|
|
‡a
gastriccardiacarcinomaisassociatedwiththepromoter77t100genepolymorphismof10raycrosscomplementinggroup1
‡A
Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-ray cross-complementing group 1
‡9
1
|
919
|
|
|
‡a
ecadherinimpairmentincreasescellsurvivalthroughnotchdependentupregulationofbcl2
‡A
E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2
‡9
1
|
919
|
|
|
‡a
mucoepidermoidcarcinomaofthethyroidatumourhistotypecharacterisedbypcadherinneoexpressionandmarkedabnormalitiesofecadherincateninscomplex
‡A
Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex.
‡9
1
|
919
|
|
|
‡a
1degreerelativesofpatientswithearlyonsetgastriccarcinomashowevenatyoungagesahighprevalenceofadvancedolgaolgimstagesanddysplasia
‡A
First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia
‡9
1
|
919
|
|
|
‡a
gastriccardiacarcinomaisassociatedwiththepromoter77t100genepolymorphismof10raycrosscomplementinggroup1xrcc1
‡A
Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-ray cross-complementing group 1 (XRCC1).
‡9
1
|
919
|
|
|
‡a
ecadheringene
‡A
E-cadherin gene
‡9
1
|
919
|
|
|
‡a
1degreerelativesofearlyonsetgastriccancerpatientsshowahighriskforgastriccancerphenotypeandgenotypeprofile
‡A
First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile
‡9
1
|
919
|
|
|
‡a
gastricmicrobialcommunityprofilingrevealsadysbioticcancerassociatedmicrobiota
‡A
Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota
‡9
1
|
919
|
|
|
‡a
ecadherinmutationsingastriccarcinoma
‡A
E-cadherin mutations in gastric carcinoma
‡9
1
|
919
|
|
|
‡a
egfrregulatesrhoagtpdependentcellmotilityinecadherinmutantcells
‡A
EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells.
‡9
1
|
919
|
|
|
‡a
1degreerelativesandfamilialaggregationofgastriccancerwhotochooseforcontrolincasecontrolstudies
‡A
First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies?
‡9
1
|
919
|
|
|
‡a
geneticvariantsarenotrareinicdcandidateswithdilatedcardiomyopathytimefornextgenerationsequencing
‡A
Genetic Variants Are Not Rare in ICD Candidates with Dilated Cardiomyopathy: Time for Next-Generation Sequencing?
‡9
1
|
919
|
|
|
‡a
epidermalgrowthfactorreceptormutationstudyfor5yearsinapopulationofpatientswithnonsmallcelllungcancer
‡A
Epidermal growth factor receptor mutation study for 5 years, in a population of patients with non-small cell lung cancer
‡9
1
|
919
|
|
|
‡a
erratumtopathogenesisofgastriccancergeneticsandmolecularclassification
‡A
Erratum to: Pathogenesis of Gastric Cancer: Genetics and Molecular Classification
‡9
1
|
919
|
|
|
‡a
lossofheterozygosityandpromotermethylationbutnotmutationmayunderlielossoftff1ingastriccarcinoma
‡A
Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma.
‡9
1
|
919
|
|
|
‡a
circulatingtumordnaastepintothefutureofcancermanagement
‡A
Circulating Tumor DNA: A Step into the Future of Cancer Management
‡9
1
|
919
|
|
|
‡a
combinedinfluenceofegf+61gaandtgfb+869t100functionalpolymorphismsinrenalcellcarcinomaprogressionandoverallsurvivalthelinktoplasmacirculatingmir7andmir221222expression
‡A
Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression
‡9
1
|
919
|
|
|
‡a
oralandgastrichelicobacterpylorieffectsandassociations
‡A
Oral and gastric Helicobacter pylori: effects and associations
‡9
1
|
919
|
|
|
‡a
krasandbrafoncogenicmutationsinmsscolorectalcarcinomaprogression
‡A
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression
‡9
1
|
919
|
|
|
‡a
interleukin1bsignallingleadstoincreasedsurvivalofgastriccarcinomacellsthroughacreb100ebpβassociatedmechanism
‡A
Interleukin-1B signalling leads to increased survival of gastric carcinoma cells through a CREB-C/EBPβ-associated mechanism
‡9
1
|
919
|
|
|
‡a
geneticandepigeneticalterationingastriccarcinogenesis
‡A
Genetic and epigenetic alteration in gastric carcinogenesis
‡9
1
|
919
|
|
|
‡a
recellularphenotypesofdifferentiatedtypeadenocarcinomasandprecancerouslesionsofthestomacharedependentonthegeneticpathways
‡A
Re. ‘Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways’
‡9
1
|
919
|
|
|
‡a
msi50gastriccarcinomassharethehmlh1methylationstatusofmsihcarcinomasbutnottheirclinicopathologicalprofile
‡A
MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile
‡9
1
|
919
|
|
|
‡a
molecularcharacterizationofportuguesepatientswithdilatedcardiomyopathy
‡A
Molecular characterization of Portuguese patients with dilated cardiomyopathy
‡9
1
|
919
|
|
|
‡a
ecadherinchangesingastriccarcimona
‡A
E-cadherin changes in gastric carcimona
‡9
1
|
919
|
|
|
‡a
variabledistributionoftff2spasmolysinallelesineuropeansdoesnotindicatepredispositiontogastriccancer
‡A
Variable distribution of TFF2 (Spasmolysin) alleles in Europeans does not indicate predisposition to gastric cancer
‡9
1
|
919
|
|
|
‡a
ccaatenhancerbindingproteinβ100ebpβisoformsastranscriptionalregulatorsoftheproinvasivecdh3pcadheringeneinhumanbreastcancercells
‡A
CCAAT/enhancer binding protein β (C/EBPβ) isoforms as transcriptional regulators of the pro-invasive CDH3/P-cadherin gene in human breast cancer cells
‡9
1
|
919
|
|
|
‡a
nonopticalmassiveparalleldnasequencingofbrca1andbrca2genesinadiagnosticsetting
‡A
Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting.
‡9
1
|
919
|
|
|
‡a
molecularpathogenesisofgastriccancer
‡A
Molecular pathogenesis of gastric cancer.
‡9
1
|
919
|
|
|
‡a
variabledistributionoftff2
‡A
Variable distribution of TFF2
‡9
1
|
919
|
|
|
‡a
bonemineraldensityinvocationalandprofessionalballetdancers
‡A
Bone mineral density in vocational and professional ballet dancers
‡9
1
|
919
|
|
|
‡a
bonemassoffemaledancestudentspriortoprofessionaldancetrainingacrosssectionalstudy
‡A
Bone mass of female dance students prior to professional dance training: A cross-sectional study
‡9
1
|
919
|
|
|
‡a
reviewgastricmalignanciesbasicaspects
‡A
Review: Gastric malignancies: Basic aspects
‡9
1
|
919
|
|
|
‡a
betacateninctnnb1geneamplificationanewmechanismofproteinoverexpressionincancer
‡A
beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer.
‡9
1
|
919
|
|
|
‡a
detectionofcommonandlessfrequentegfrmutationsincytologicalsamplesoflungcancer
‡A
Detection of Common and Less FrequentEGFRMutations in Cytological Samples of Lung Cancer
‡9
1
|
919
|
|
|
‡a
associationbetweenfunctionalegf+61polymorphismandgliomarisk
‡A
Association between functional EGF+61 polymorphism and glioma risk.
‡9
1
|
919
|
|
|
‡a
associationbetweencytokinegenepolymorphismsandgastricprecancerouslesionssystematicreviewandmetaanalysis
‡A
Association between cytokine gene polymorphisms and gastric precancerous lesions: systematic review and meta-analysis
‡9
1
|
919
|
|
|
‡a
identificationofgermlineecadherinmutationsingastriccancerfamiliesofeuropeanorigin
‡A
Identification of germ-line E-cadherin mutations in gastric cancer families of European origin
‡9
1
|
919
|
|
|
‡a
1rnvntrpolymorphismandgeneticsusceptibilitytocervicalcancerinportugal
‡A
IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal.
‡9
1
|
919
|
|
|
‡a
1rnvntrpolymorphismasasusceptibilitymarkerfornasopharyngealcarcinomainportugal
‡A
IL-1RN VNTR polymorphism as a susceptibility marker for nasopharyngeal carcinoma in Portugal.
‡9
1
|
919
|
|
|
‡a
valueofmoleculardiagnosisinafamilywithmarfansyndromeandanatypicalvascularphenotype
‡A
Value of molecular diagnosis in a family with Marfan syndrome and an atypical vascular phenotype
‡9
1
|
919
|
|
|
‡a
ps2proteinexpressioningastriccarcinomaanimmunohistochemicalandimmunoradiometricstudy
‡A
pS2 protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric study
‡9
1
|
919
|
|
|
‡a
phenotypegenotypeprofilesincrohnsdiseasepredictedbygeneticmarkersinautophagyrelatedgenes
‡A
Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes
‡9
1
|
919
|
|
|
‡a
differentpatternsofbetacateninexpressioningastriccarcinomasrelationshipwithclinicopathologicalparametersandprognosticoutcome
‡A
Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome
‡9
1
|
919
|
|
|
‡a
novel25bptandemrepeatwithinthehumantrefoilpeptidegenetff2in21q223polymorphismandmammalianevolution
‡A
A novel 25 bp tandem repeat within the human trefoil peptide gene TFF2 in 21q22.3: polymorphism and mammalian evolution
‡9
1
|
919
|
|
|
‡a
urothelialdysplasiaandinflammationinducedbyschistosomahaematobiumtotalantigeninstillationinmicenormalurothelium
‡A
Urothelial dysplasia and inflammation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium
‡9
1
|
919
|
|
|
‡a
novelmethodforgenotypingthehelicobacterpylorivacaintermediateregiondirectlyingastricbiopsyspecimens
‡A
A novel method for genotyping the Helicobacter pylori vacA intermediate region directly in gastric biopsy specimens
‡9
1
|
919
|
|
|
‡a
tumourigeniceffectofschistosomahaematobiumtotalantigeninmammaliancells
‡A
Tumourigenic effect of Schistosoma haematobium total antigen in mammalian cells.
‡9
1
|
919
|
|
|
‡a
nod2card15andtnfabutnotillbandillrnareassociatedwithcrohnsdisease
‡A
NOD2/CARD15 and TNFA, But Not ILLB and ILLRN, are Associated With Crohnʼs Disease
‡9
1
|
919
|
|
|
‡a
establishmentandcharacterizationof2celllinesderivedfromhumandiffusegastriccarcinomasxenograftedinnudemice
‡A
Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice.
‡9
1
|
919
|
|
|
‡a
tumornecrosisfactoralphaextendedhaplotypesandriskofgastriccarcinoma
‡A
Tumor Necrosis Factor Alpha Extended Haplotypes and Risk of Gastric Carcinoma
‡9
1
|
919
|
|
|
‡a
mixedcarcinomaofthestomachaclinicopathologicalentity
‡A
Mixed carcinoma of the stomach: a clinicopathological entity
‡9
1
|
919
|
|
|
‡a
trefoilfactorsfromulcerationtoneoplasia
‡A
Trefoil factors: from ulceration to neoplasia.
‡9
1
|
919
|
|
|
‡a
concurrenthypermethylationofgenepromotersisassociatedwithamsihphenotypeanddiploidyingastriccarcinomas
‡A
Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas.
‡9
1
|
919
|
|
|
‡a
mitochondrialdnaalterationingastriccancer
‡A
Mitochondrial DNA alteration in gastric cancer
‡9
1
|
919
|
|
|
‡a
clinicalrelevanceofhelicobacterpylorivacaandcagagenotypesingastriccarcinoma
‡A
Clinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma
‡9
1
|
919
|
|
|
‡a
2facesoftumorassociatedmacrophagesandtheirclinicalsignificanceincolorectalcancer
‡A
The Two Faces of Tumor-Associated Macrophages and Their Clinical Significance in Colorectal Cancer
‡9
1
|
919
|
|
|
‡a
prevalenceofpik3camutationsingastricandcoloncancer
‡A
The prevalence of PIK3CA mutations in gastric and colon cancer.
‡9
1
|
919
|
|
|
‡a
numberofhelicobacterpyloricagaepiya100tyrosinephosphorylationmotifsinfluencesthepatternofgastritisandthedevelopmentofgastriccarcinoma
‡A
The number of Helicobacter pylori CagA EPIYA C tyrosine phosphorylation motifs influences the pattern of gastritis and the development of gastric carcinoma.
‡9
1
|
919
|
|
|
‡a
commonvascularendothelialgrowthfactorvariantsandriskforposttransplantkaposisarcoma
‡A
Common Vascular Endothelial Growth Factor Variants and Risk for Posttransplant Kaposi Sarcoma
‡9
1
|
919
|
|
|
‡a
roleofepidermalgrowthfactormutationalstatusfordistinctionbetweenrecurrentlungcancerand2primarylungcancercasereport
‡A
Role of epidermal growth factor mutational status for distinction between recurrent lung cancer and second primary lung cancer: case report
‡9
1
|
919
|
|
|
‡a
inductionofapoptosisincreasessensitivitytodetectcancermutationsinplasma
‡A
Induction of apoptosis increases sensitivity to detect cancer mutations in plasma
‡9
1
|
919
|
|
|
‡a
interleukin8251tapolymorphismisnotassociatedwithriskforgastriccarcinomadevelopmentinaportuguesepopulation
‡A
The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population
‡9
1
|
919
|
|
|
‡a
integrationofnextgenerationsequencinginclinicaldiagnosticmolecularpathologylaboratoriesforanalysisofsolidtumoursanexpertopiniononbehalfofiqnpathasbl
‡A
Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL.
‡9
1
|
919
|
|
|
‡a
interferongammareceptor1ifngr156ctgenepolymorphismisassociatedwithincreasedriskofearlygastriccarcinoma
‡A
The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma
‡9
1
|
919
|
|
|
‡a
exosomesandimmuneresponseincancerfriendsorfoes
‡A
Exosomes and Immune Response in Cancer: Friends or Foes?
‡9
1
|
919
|
|
|
‡a
apolipoproteinee4alleledoesnotincreasetheriskofearlypostoperativedeliriumaftermajorsurgery
‡A
Apolipoprotein E e4 allele does not increase the risk of early postoperative delirium after major surgery
‡9
1
|
919
|
|
|
‡a
g308atnfαpolymorphismisassociatedwithanincreasedriskofinvasivecervicalcancer
‡A
G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer
‡9
1
|
919
|
|
|
‡a
routinecharacterizationofbiomarkersinnonsmallcelllungcarcinomahowmuchisenough
‡A
Routine characterization of biomarkers in non-small cell lung carcinoma: how much is enough?
‡9
1
|
919
|
|
|
‡a
lrp5genepolymorphismsandradiographicjointdamageinrheumatoidarthritispatients
‡A
LRP5 gene polymorphisms and radiographic joint damage in rheumatoid arthritis patients
‡9
1
|
919
|
|
|
‡a
identificationofcdh1germlinemissensemutationsassociatedwithfunctionalinactivationoftheecadherinproteininyounggastriccancerprobands
‡A
Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands
‡9
1
|
919
|
|
|
‡a
ecadherincdh1andp53ratherthansmad4andcaspase10germlinemutationscontributetogeneticpredispositioninportuguesegastriccancerpatients
‡A
E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
‡9
1
|
919
|
|
|
‡a
ecadherin
‡A
E-Cadherin
‡9
1
|
919
|
|
|
‡a
100ebpbetaisoverexpressedingastriccarcinogenesisandisassociatedwithcox2expression
‡A
C/EBPbeta is over-expressed in gastric carcinogenesis and is associated with COX-2 expression
‡9
1
|
919
|
|
|
‡a
100ebpαexpressionisassociatedwithhomeostasisofthegastricepitheliumandwithgastriccarcinogenesis
‡A
C/EBPα expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis
‡9
1
|
919
|
|
|
‡a
differentialexpressionofmucinsandtrefoilpeptidesinnativeepitheliumbarrettsmetaplasiaandsquamouscellcarcinomaoftheoesophagus
‡A
Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus
‡9
1
|
919
|
|
|
‡a
multicenterevaluationoftheidyllanrasbrafmutationtestinmetastaticcolorectalcancer
‡A
Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer
‡9
1
|
919
|
|
|
‡a
interleukin1bandinterleukin1rnpolymorphismsareassociatedwithincreasedriskofgastriccarcinoma
‡A
Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma
‡9
1
|
919
|
|
|
‡a
criteriatopredictcarriersofanovelscn5amutationinalargeportuguesefamilyaffectedbythebrugadasyndrome
‡A
Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome
‡9
1
|
919
|
|
|
‡a
promotermethylationoftgfbetareceptor1andmutationoftgfbetareceptor2arefrequenteventsinmsisporadicgastriccarcinomas
‡A
Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas
‡9
1
|
919
|
|
|
‡a
geneticvariantsidentifiedbytargetnextgenerationsequencinginhearttransplantpatientswithdilatedcardiomyopathy
‡A
Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
‡9
1
|
919
|
|
|
‡a
core1geneisoverexpressedinhurthleandnonhurthlecellmicrofollicularadenomasandfollicularcarcinomasofthethyroid
‡A
Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid
‡9
1
|
919
|
|
|
‡a
gastriccancerbasicaspects
‡A
Gastric cancer: Basic aspects
‡9
1
|
919
|
|
|
‡a
docosahexaenoicacidloadedlipidnanoparticleswithbactericidalactivityagainsthelicobacterpylori
‡A
Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori.
‡9
1
|
919
|
|
|
‡a
ici182780inducespcadherinoverexpressioninbreastcancercellsthroughchromatinremodellingatthepromoterlevelarolefor100ebpbetaincdh3geneactivation
‡A
ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation
‡9
1
|
919
|
|
|
‡a
overallsurvivalanalysisandcharacterizationofanegfrmutatednonsmallcelllungcancer
‡A
Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer
‡9
1
|
919
|
|
|
‡a
ancillarystudiesincludingimmunohistochemistryandmolecularstudiesinlungcytology
‡A
Ancillary Studies, Including Immunohistochemistry and Molecular Studies, in Lung Cytology.
‡9
1
|
919
|
|
|
‡a
docosahexaenoicacidinhibitshelicobacterpylorigrowthinvitroandmicegastricmucosacolonization
‡A
Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization
‡9
1
|
919
|
|
|
‡a
interferongammareceptor1
‡A
The interferon gamma receptor 1
‡9
1
|
919
|
|
|
‡a
ccaatenhancerbindingproteinβ
‡A
CCAAT/enhancer binding protein β
‡9
1
|
919
|
|
|
‡a
targetingmolecularsignalingpathwaysofschistosomahaemotobiuminfectioninbladdercancer
‡A
Targeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer
‡9
1
|
919
|
|
|
‡a
targetedgenenextgenerationsequencingpanelinpatientswithadvancedlungadenocarcinomapavingthewayforclinicalimplementation
‡A
Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation
‡9
1
|
919
|
|
|
‡a
overallsurvivalanalysisandcharacterizationofanegfrmutatednonsmallcelllungcancernsclcpopulation
‡A
Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population
‡9
1
|
919
|
|
|
‡a
geneticsofglucocorticoidregulationandposttraumaticstressdisorderwhatdoweknow
‡A
Genetics of glucocorticoid regulation and posttraumatic stress disorder--What do we know?
‡9
1
|
919
|
|
|
‡a
geneticvariantsintheil1ageneregioncontributetointestinaltypegastriccarcinomasusceptibilityineuropeanpopulations
‡A
Genetic variants in the IL1A gene region contribute to intestinal-type gastric carcinoma susceptibility in European populations
‡9
1
|
919
|
|
|
‡a
primarysignetringcellcarcinomasofthelung
‡A
Primary signet-ring cell carcinomas of the lung
‡9
1
|
919
|
|
|
‡a
systematicreviewgastricmicrobiotainhealthanddisease
‡A
Systematic review: gastric microbiota in health and disease
‡9
1
|
919
|
|
|
‡a
cagaassociateswith100metecadherinandp120catenininamultiproteiccomplexthatsuppresseshelicobacterpyloriinducedcellinvasivephenotype
‡A
CagA associates with c-Met, E-cadherin, and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype
‡9
1
|
919
|
|
|
‡a
europeanregistryonhelicobacterpylorimanagementhpeuregpatternsandtrendsin1lineempiricaleradicationprescriptionandoutcomesof5yearsand21533patients
‡A
European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients
‡9
1
|
919
|
|
|
‡a
patternsofbetacateninexpressioningastriccarcinomaclinicopathologicalrelevanceandmutationanalysis
‡A
Patterns of beta-catenin expression in gastric carcinoma: clinicopathological relevance and mutation analysis.
‡9
1
|
919
|
|
|
‡a
simultaneousdetectionoflungfusionsusingamultiplexrtpcrnextgenerationsequencingbasedapproachamultiinstitutionalresearchstudy
‡A
Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study
‡9
1
|
919
|
|
|
‡a
criteriosdediagnosticodasindromedebrugadapodemosmelhorar
‡A
Critérios de diagnóstico da Síndrome de Brugada. Podemos melhorar?
‡9
1
|
919
|
|
|
‡a
correctionforferreiraetalanovelmethodforgenotypingthehelicobacterpylorivacaintermediateregiondirectlyingastricbiopsyspecimens
‡A
Correction for Ferreira et al., A Novel Method for Genotyping the Helicobacter pylori vacA Intermediate Region Directly in Gastric Biopsy Specimens
‡9
1
|
919
|
|
|
‡a
geneticvariationinwntβcateninandersignallingpathwaysinfemaleandmaleelitedancersanditsassociationswithlowbonemineraldensityacrosssectionandlongitudinalstudy
‡A
Genetic variation in Wnt/β-catenin and ER signalling pathways in female and male elite dancers and its associations with low bone mineral density: a cross-section and longitudinal study
‡9
1
|
919
|
|
|
‡a
crosstalkbetweenhelicobacterpyloriandgastricepithelialcellsisimpairedbydocosahexaenoicacid
‡A
Crosstalk between Helicobacter pylori and gastric epithelial cells is impaired by docosahexaenoic acid
‡9
1
|
919
|
|
|
‡a
100ebpβregulateshomeostaticandoncogenicgastriccellproliferation
‡A
C/EBPβ regulates homeostatic and oncogenic gastric cell proliferation
‡9
1
|
919
|
|
|
‡a
schistosomahaematobiumtotalantigeninducesincreasedproliferationmigrationandinvasionanddecreasesapoptosisofnormalepithelialcells
‡A
Schistosoma haematobium total antigen induces increased proliferation, migration and invasion, and decreases apoptosis of normal epithelial cells
‡9
1
|
919
|
|
|
‡a
femalesexhormonereceptorsarenotinvolvedingastriccarcinogenesisabiochemicalandimmunohistochemicalstudy
‡A
Female sex hormone receptors are not involved in gastric carcinogenesis. A biochemical and immunohistochemical study.
‡9
1
|
919
|
|
|
‡a
patternofps2proteinexpressioninpremalignantandmalignantlesionsofgastricmucosa
‡A
Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa.
‡9
1
|
919
|
|
|
‡a
pathogenesisofhelicobacterpyloriinfection
‡A
Pathogenesis of Helicobacter pylori Infection
‡9
1
|
919
|
|
|
‡a
pathogenesisofgastriccancergeneticsandmolecularclassification
‡A
Pathogenesis of Gastric Cancer: Genetics and Molecular Classification.
‡9
1
|
919
|
|
|
‡a
glycansasimmunecheckpointsremovalofbranchednglycansenhancesimmunerecognitionpreventingcancerprogression
‡A
Glycans as immune checkpoints: removal of branched N-glycans enhances immune recognition preventing cancer progression
‡9
1
|
919
|
|
|
‡a
granulomatouslikeimmunereactionandhepaticfibrosisinducedbyschistosomahaematobiumimmatureworms
‡A
Granulomatous-like immune reaction and hepatic fibrosis induced by Schistosoma haematobium immature worms
‡9
1
|
919
|
|
|
‡a
schistosomahaematobiumidentificationofnewestrogenicmoleculeswithestradiolantagonisticactivityandabilitytoinactivateestrogenreceptorinmammaliancells
‡A
Schistosoma haematobium: identification of new estrogenic molecules with estradiol antagonistic activity and ability to inactivate estrogen receptor in mammalian cells
‡9
1
|
919
|
|
|
‡a
geneticscreeningforfamilialgastriccancer
‡A
Genetic screening for familial gastric cancer
‡9
1
|
919
|
|
|
‡a
schistosomahaematobiumandschistosomiasismansoniproductionofanestradiolrelatedcompounddetectedbyelisa
‡A
Schistosoma haematobium and Schistosomiasis mansoni: production of an estradiol-related compound detected by ELISA.
‡9
1
|
919
|
|
|
‡a
schistosomahaematobiumandbladdercancerwhatliesbeneath
‡A
Schistosoma haematobium and bladder cancer: what lies beneath?
‡9
1
|
919
|
|
|
‡a
microsatelliteinstabilityinhyperplasticandadenomatouspolypsofthestomach
‡A
Microsatellite instability in hyperplastic and adenomatous polyps of the stomach
‡9
1
|
919
|
|
|
‡a
currentthoughtsonthehistopathogenesisofgastriccancer
‡A
Current thoughts on the histopathogenesis of gastric cancer.
‡9
1
|
919
|
|
|
‡a
grim19mutationsarenotassociatedwithcrohnsdisease
‡A
GRIM-19 mutations are not associated with Crohn's disease.
‡9
1
|
919
|
|
|
‡a
helicobacterpyloriandinterleukin1genotypinganopportunitytoidentifyhighriskindividualsforgastriccarcinoma
‡A
Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma
‡9
1
|
919
|
|
|
‡a
extensivegeneticpolymorphismofpeptidasesab100and500inwildrabbitoryctolaguscuniculuspopulationsfromtheiberianpeninsula
‡A
Extensive genetic polymorphism of peptidases A, B, C, and D, in wild rabbit (Oryctolagus cuniculus) populations from the Iberian Peninsula
‡9
1
|
919
|
|
|
‡a
newinsightsintotheinflamedtumorimmunemicroenvironmentofgastriccancerwithlymphoidstromafrommorphologyanddigitalanalysistogeneexpression
‡A
New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression
‡9
1
|
919
|
|
|
‡a
prevalenceoflowbonemineraldensityinfemaledancers
‡A
Prevalence of low bone mineral density in female dancers
‡9
1
|
919
|
|
|
‡a
helicobacterpyloriinducesgastricepithelialcellinvasionina100metandtype4secretionsystemdependentmanner
‡A
Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner
‡9
1
|
919
|
|
|
‡a
helicobacterpylorischolesteroluptakeimpactsresistancetodocosahexaenoicacid
‡A
Helicobacter pylori's cholesterol uptake impacts resistance to docosahexaenoic acid.
‡9
1
|
919
|
|
|
‡a
newmassiveparallelsequencingapproachimprovesthegeneticcharacterizationofcongenitalmyopathies
‡A
New massive parallel sequencing approach improves the genetic characterization of congenital myopathies
‡9
1
|
919
|
|
|
‡a
heterozygousgermlinemutationsina2ml1areassociatedwithadisorderclinicallyrelatedtonoonansyndrome
‡A
Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome.
‡9
1
|
919
|
|
|
‡a
polymorphismsinthetnfaandil6genesrepresentriskfactorsforautoimmunethyroiddisease
‡A
Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease
‡9
1
|
919
|
|
|
‡a
polymorphismsininflammatoryresponsegenesandtheirassociationwithgastriccancerahugesystematicreviewandmetaanalyses
‡A
Polymorphisms in Inflammatory Response Genes and Their Association With Gastric Cancer: A HuGE Systematic Review and Meta-Analyses
‡9
1
|
919
|
|
|
‡a
diagnosticchallengesofmarfansyndromeinanxyyyoungman
‡A
Diagnostic challenges of Marfan syndrome in an XYY young man
‡9
1
|
919
|
|
|
‡a
proinflammatorygeneticprofileincreasestheriskforchronicatrophicgastritisandgastriccarcinoma
‡A
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma
‡9
1
|
919
|
|
|
‡a
pathogenesisofgastriccancer
‡A
Pathogenesis of Gastric Cancer.
‡9
1
|
919
|
|
|
‡a
expressionpatternofgastrointestinalmarkersinnativecolorectalepitheliumlesionsandcarcinomas
‡A
Expression pattern of gastrointestinal markers in native colorectal epithelium, lesions, and carcinomas
‡9
1
|
919
|
|
|
‡a
phenotypegenotypeprofilesincrohnsdiseasepredictedbygeneticmarkersinautophagyrelatedgenesgoiastudy2
‡A
Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II).
‡9
1
|
919
|
|
|
‡a
geneticchangesofcebpaincancermutationsorpolymorphisms
‡A
Genetic Changes of CEBPA in Cancer: Mutations or Polymorphisms?
‡9
1
|
919
|
|
|
‡a
inactivationofestrogenreceptorbyschistosomahaematobiumtotalantigeninbladderurothelialcells
‡A
Inactivation of estrogen receptor by Schistosoma haematobium total antigen in bladder urothelial cells
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
BLBNB|000284868
|
996
|
|
|
‡2
BLBNB|000284869
|
996
|
|
|
‡2
ISNI|0000000077387638
|
996
|
|
|
‡2
LC|n 2016257911
|
996
|
|
|
‡2
BLBNB|000284862
|
996
|
|
|
‡2
BLBNB|000284863
|
996
|
|
|
‡2
ISNI|0000000067810439
|
996
|
|
|
‡2
BNCHL|10000000000000000134642
|
996
|
|
|
‡2
BLBNB|000284865
|
996
|
|
|
‡2
DNB|1012496546
|
996
|
|
|
‡2
PTBNP|1553179
|
996
|
|
|
‡2
PTBNP|1057151
|
996
|
|
|
‡2
ISNI|0000000428055257
|
996
|
|
|
‡2
LC|n 79010094
|
996
|
|
|
‡2
ISNI|0000000069514537
|
996
|
|
|
‡2
ISNI|0000000070126275
|
996
|
|
|
‡2
PTBNP|1376858
|
996
|
|
|
‡2
ISNI|0000000052206036
|
996
|
|
|
‡2
DNB|1157162916
|
996
|
|
|
‡2
BLBNB|000281982
|
996
|
|
|
‡2
CAOONL|ncf10285126
|
996
|
|
|
‡2
BIBSYS|90756256
|
996
|
|
|
‡2
PTBNP|1895302
|
996
|
|
|
‡2
BLBNB|000546510
|
996
|
|
|
‡2
LC|n 88604961
|
996
|
|
|
‡2
PTBNP|47784
|
996
|
|
|
‡2
LC|n 2022048990
|
996
|
|
|
‡2
SUDOC|114659826
|
996
|
|
|
‡2
NII|DA03367420
|
996
|
|
|
‡2
BAV|495_51106
|
996
|
|
|
‡2
BAV|495_51105
|
996
|
|
|
‡2
NUKAT|n 2017057144
|
996
|
|
|
‡2
N6I|vtls001107100
|
996
|
|
|
‡2
ISNI|0000000069194107
|
996
|
|
|
‡2
ISNI|0000000038082436
|
996
|
|
|
‡2
BLBNB|001021648
|
996
|
|
|
‡2
BNCHL|10000000000000000048308
|
996
|
|
|
‡2
LC|n 00037683
|
996
|
|
|
‡2
LC|n 2024255193
|
996
|
|
|
‡2
ISNI|000000006910436X
|
996
|
|
|
‡2
ISNI|0000000044420550
|
996
|
|
|
‡2
BLBNB|000306556
|
996
|
|
|
‡2
ISNI|0000000116580781
|
996
|
|
|
‡2
PTBNP|1278153
|
996
|
|
|
‡2
BLBNB|000379792
|
996
|
|
|
‡2
LC|no2003100518
|
996
|
|
|
‡2
NTA|384120415
|
996
|
|
|
‡2
ISNI|0000000069603230
|
996
|
|
|
‡2
ISNI|0000000122705261
|
996
|
|
|
‡2
SUDOC|266772323
|
996
|
|
|
‡2
PTBNP|236468
|
996
|
|
|
‡2
LC|nb2023016929
|
996
|
|
|
‡2
BLBNB|000546161
|
996
|
|
|
‡2
ISNI|000000008108228X
|
996
|
|
|
‡2
BLBNB|000619100
|
996
|
|
|
‡2
BLBNB|001423059
|
996
|
|
|
‡2
LC|nb2015016289
|
996
|
|
|
‡2
ISNI|0000000120222143
|
996
|
|
|
‡2
ISNI|0000000068485391
|
996
|
|
|
‡2
BLBNB|000594659
|
996
|
|
|
‡2
BNC|981058519118306706
|
996
|
|
|
‡2
PTBNP|1869174
|
996
|
|
|
‡2
CAOONL|ncf11464932
|
996
|
|
|
‡2
ISNI|0000000070027437
|
996
|
|
|
‡2
BLBNB|000355256
|
996
|
|
|
‡2
ISNI|000000006831906X
|
996
|
|
|
‡2
ISNI|0000000069601550
|
996
|
|
|
‡2
LC|nb2007006590
|
996
|
|
|
‡2
BNF|12061336
|
996
|
|
|
‡2
PTBNP|1886622
|
996
|
|
|
‡2
PTBNP|1566691
|
996
|
|
|
‡2
ISNI|0000000059352351
|
996
|
|
|
‡2
LC|no2009044368
|
996
|
|
|
‡2
LC|n 85046049
|
996
|
|
|
‡2
ISNI|000000012209830X
|
996
|
|
|
‡2
PTBNP|1508036
|
996
|
|
|
‡2
PTBNP|78171
|
996
|
|
|
‡2
DNB|1074682319
|
996
|
|
|
‡2
ISNI|0000000021769434
|
996
|
|
|
‡2
DNB|1253146896
|
996
|
|
|
‡2
LC|nb2004011194
|
996
|
|
|
‡2
BLBNB|000285177
|
996
|
|
|
‡2
ISNI|0000000117715844
|
996
|
|
|
‡2
BLBNB|000355689
|
996
|
|
|
‡2
BAV|495_110825
|
996
|
|
|
‡2
DNB|1057360724
|
996
|
|
|
‡2
PTBNP|1852740
|
996
|
|
|
‡2
PTBNP|61358
|
996
|
|
|
‡2
DNB|1025972252
|
996
|
|
|
‡2
PTBNP|122028
|
996
|
|
|
‡2
LNB|LNC10-000340427
|
996
|
|
|
‡2
SUDOC|255605560
|
996
|
|
|
‡2
PTBNP|1864744
|
996
|
|
|
‡2
BLBNB|000626467
|
996
|
|
|
‡2
SELIBR|335446
|
996
|
|
|
‡2
BLBNB|000448052
|
996
|
|
|
‡2
DNB|117661120
|
996
|
|
|
‡2
LC|n 2014042336
|
996
|
|
|
‡2
LC|n 2015235847
|
996
|
|
|
‡2
ISNI|0000000436097596
|
996
|
|
|
‡2
NTA|155414151
|
996
|
|
|
‡2
LC|n 2015235523
|
996
|
|
|
‡2
BLBNB|000296048
|
996
|
|
|
‡2
LC|no2023059293
|
996
|
|
|
‡2
PTBNP|184641
|
996
|
|
|
‡2
SUDOC|157140415
|
996
|
|
|
‡2
BLBNB|001542804
|
996
|
|
|
‡2
BLBNB|000432216
|
996
|
|
|
‡2
BLBNB|000598763
|
996
|
|
|
‡2
ISNI|0000000025324846
|
996
|
|
|
‡2
PTBNP|254927
|
996
|
|
|
‡2
SUDOC|175663033
|
996
|
|
|
‡2
PTBNP|1900561
|
996
|
|
|
‡2
ISNI|000000007002675X
|
996
|
|
|
‡2
ISNI|0000000069220205
|
996
|
|
|
‡2
LC|n 2018058914
|
996
|
|
|
‡2
RERO|A003726485
|
996
|
|
|
‡2
LC|no2003067009
|
996
|
|
|
‡2
DNB|1056205784
|
996
|
|
|
‡2
BLBNB|000278285
|
996
|
|
|
‡2
ISNI|0000000052092833
|
996
|
|
|
‡2
LC|n 82204281
|
996
|
|
|
‡2
PTBNP|1581257
|
996
|
|
|
‡2
RERO|A003918626
|
996
|
|
|
‡2
BLBNB|000476906
|
996
|
|
|
‡2
PTBNP|942138
|
996
|
|
|
‡2
BLBNB|000561659
|
996
|
|
|
‡2
PTBNP|208945
|
996
|
|
|
‡2
NKC|vut2012704131
|
996
|
|
|
‡2
LIH|LNB:CM___k_;=B_b_
|
996
|
|
|
‡2
LC|n 92020341
|
996
|
|
|
‡2
ISNI|0000000078091839
|
996
|
|
|
‡2
SUDOC|056868685
|
996
|
|
|
‡2
CAOONL|ncf11299544
|
996
|
|
|
‡2
ISNI|0000000027182191
|
996
|
|
|
‡2
SUDOC|132623374
|
996
|
|
|
‡2
CAOONL|ncf11187235
|
996
|
|
|
‡2
LC|n 96067746
|
996
|
|
|
‡2
LC|n 2024256423
|
996
|
|
|
‡2
PTBNP|61516
|
996
|
|
|
‡2
BLBNB|000285428
|
996
|
|
|
‡2
LC|n 2015247895
|
996
|
|
|
‡2
DNB|138178720
|
996
|
|
|
‡2
PTBNP|1825703
|
996
|
|
|
‡2
ISNI|0000000068096011
|
996
|
|
|
‡2
PTBNP|1794341
|
996
|
|
|
‡2
PTBNP|1684521
|
996
|
|
|
‡2
ISNI|0000000119925597
|
996
|
|
|
‡2
PTBNP|1635628
|
996
|
|
|
‡2
DNB|1159018332
|
996
|
|
|
‡2
ISNI|0000000454416765
|
996
|
|
|
‡2
LC|n 2013200410
|
996
|
|
|
‡2
ISNI|0000000036980910
|
996
|
|
|
‡2
PTBNP|1854913
|
996
|
|
|
‡2
BLBNB|000238331
|
996
|
|
|
‡2
SUDOC|137438079
|
996
|
|
|
‡2
LC|n 82108261
|
996
|
|
|
‡2
PTBNP|81000
|
996
|
|
|
‡2
DNB|1056375485
|
996
|
|
|
‡2
ISNI|0000000024937384
|
996
|
|
|
‡2
LC|n 86001150
|
996
|
|
|
‡2
BLBNB|001469081
|
996
|
|
|
‡2
DNB|1057673951
|
996
|
|
|
‡2
BLBNB|000426926
|
996
|
|
|
‡2
PTBNP|1778263
|
996
|
|
|
‡2
BLBNB|000474537
|
996
|
|
|
‡2
ISNI|0000000070106557
|
996
|
|
|
‡2
LC|n 2007034589
|
996
|
|
|
‡2
CAOONL|ncf11278791
|
996
|
|
|
‡2
ISNI|0000000068787824
|
996
|
|
|
‡2
PTBNP|31242
|
996
|
|
|
‡2
NKC|jo20221159818
|
996
|
|
|
‡2
BNF|16201152
|
996
|
|
|
‡2
PTBNP|1215697
|
996
|
|
|
‡2
LC|nr 88009097
|
996
|
|
|
‡2
ISNI|0000000020330876
|
996
|
|
|
‡2
NSK|000740946
|
996
|
|
|
‡2
BAV|495_51100
|
996
|
|
|
‡2
ISNI|0000000050725043
|
996
|
|
|
‡2
NTA|074792709
|
996
|
|
|
‡2
DNB|170902390
|
996
|
|
|
‡2
LC|no2002015816
|
996
|
|
|
‡2
SUDOC|20269898X
|
996
|
|
|
‡2
PTBNP|1560174
|
996
|
|
|
‡2
BLBNB|000536553
|
996
|
|
|
‡2
DNB|1025443349
|
996
|
|
|
‡2
ISNI|0000000077387347
|
996
|
|
|
‡2
BLBNB|001484392
|
996
|
|
|
‡2
NUKAT|nx2024068724
|
996
|
|
|
‡2
DNB|1057423467
|
996
|
|
|
‡2
PTBNP|1923009
|
996
|
|
|
‡2
PTBNP|1463037
|
996
|
|
|
‡2
DNB|1052886205
|
996
|
|
|
‡2
ISNI|0000000499997321
|
996
|
|
|
‡2
PTBNP|365906
|
996
|
|
|
‡2
LC|n 84121065
|
996
|
|
|
‡2
NUKAT|n 2019152993
|
996
|
|
|
‡2
SUDOC|279520948
|
996
|
|
|
‡2
LC|no 00021884
|
996
|
|
|
‡2
DNB|143677780
|
996
|
|
|
‡2
ISNI|0000000081692926
|
996
|
|
|
‡2
ISNI|0000000410168691
|
996
|
|
|
‡2
PTBNP|260001
|
996
|
|
|
‡2
PTBNP|61374
|
996
|
|
|
‡2
NTA|067871879
|
996
|
|
|
‡2
ISNI|0000000036929736
|
996
|
|
|
‡2
PTBNP|44256
|
996
|
|
|
‡2
LC|no2002084972
|
996
|
|
|
‡2
LC|n 91022393
|
996
|
|
|
‡2
DNB|1030244308
|
996
|
|
|
‡2
NUKAT|n 2010233515
|
996
|
|
|
‡2
LC|no2023002707
|
996
|
|
|
‡2
J9U|987007400151305171
|
996
|
|
|
‡2
BLBNB|000285187
|
996
|
|
|
‡2
BLBNB|000284840
|
996
|
|
|
‡2
NII|DA12787176
|
996
|
|
|
‡2
BLBNB|001468478
|
996
|
|
|
‡2
BLBNB|000329482
|
996
|
|
|
‡2
ISNI|000000003270170X
|
996
|
|
|
‡2
LC|n 2003148637
|
996
|
|
|
‡2
PTBNP|1431166
|
996
|
|
|
‡2
DNB|1057599743
|
996
|
|
|
‡2
ISNI|000000006880644X
|
996
|
|
|
‡2
PTBNP|1091307
|
996
|
|
|
‡2
J9U|987007271164305171
|
996
|
|
|
‡2
LC|nb2008000365
|
996
|
|
|
‡2
LC|n 85031036
|
996
|
|
|
‡2
ISNI|0000000109227111
|
996
|
|
|
‡2
DNB|1234171848
|
996
|
|
|
‡2
BLBNB|000277706
|
996
|
|
|
‡2
BLBNB|000163666
|
996
|
|
|
‡2
ISNI|0000000070001990
|
996
|
|
|
‡2
BLBNB|000257328
|
996
|
|
|
‡2
PTBNP|1368703
|
996
|
|
|
‡2
ISNI|000000042827533X
|
996
|
|
|
‡2
BLBNB|000284867
|
996
|
|
|
‡2
NUKAT|n 2007117738
|
996
|
|
|
‡2
SUDOC|275532992
|
996
|
|
|
‡2
PTBNP|1878564
|
996
|
|
|
‡2
NII|DA17709817
|
996
|
|
|
‡2
DNB|1173833633
|
996
|
|
|
‡2
PTBNP|1766664
|
996
|
|
|
‡2
ISNI|0000000045808370
|
996
|
|
|
‡2
LC|n 50042030
|
996
|
|
|
‡2
BLBNB|000423164
|
996
|
|
|
‡2
PTBNP|1738405
|
996
|
|
|
‡2
BLBNB|001510024
|
996
|
|
|
‡2
J9U|987007399691005171
|
996
|
|
|
‡2
BLBNB|001586518
|
996
|
|
|
‡2
BLBNB|000487048
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
998
|
|
|
‡a
Machado, José Carlos
‡2
ISNI|0000000068787824
‡3
suggested
|
998
|
|
|
‡a
Machado, José Carlos
‡2
SUDOC|164701680
‡3
suggested
|